Financial News

French vaccine maker Valneva launches Phase 3 trial of its COVID-19 shot after snubbing EU

Study will compare how immune systems respond to Valneva’s vaccine candidate with the one jointly developed by AstraZeneca and the University of Oxford.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Feedback